Vector's (NZSE:VCT) stock is up by 4.6% over the past three months. However, its weak financial performance indicators makes us a bit doubtful if that trend could continue. Specifically, we decided to ...
Hemophilia B is a severe X-linked bleeding diathesis caused by the absence of functional blood coagulation factor IX, and is an excellent candidate for treatment of a genetic disease by gene therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback